Navigation Links
ViroPharma to Present at Three November Healthcare Conferences
Date:11/6/2008

prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, http://www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
2. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
3. ViroPharma to Present at Three October Healthcare Conferences
4. ViroPharma to Present at Three September Healthcare Conferences
5. ViroPharma To Acquire Lev Pharmaceuticals
6. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
7. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
10. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
11. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--IES(Nasdaq: IESC ),aleadingnationalp...icesforthecommercial,industrialandresidentialmarke...beenawardedacontractfromManhattanTorconJVtoinstall...4)replacementfacilityattheU.S.ArmyMedicalResearchI...kinFrederick,Md. ,, ThenewUSAMRIIDreplacementfa...
(Date:11/24/2009)...io,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCa...eds,adivisionofThompsonsLimitedofBlenheim,Ontario....iences,currentseedsbusinessasthecompanyanticipates...roSciencesHerbicideTolerantTraitTechnologyincornin...e. ,, "Thisacquisitionbringstogethertwostrongpr...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(N...firstday"motionsbytheU.S.BankruptcyCourtfortheDist...ekfiledavoluntarypetitionfor,reliefunderChapter11o...urt. , TheordersissuedbytheBankruptcyCourtall...heChapter11proceedings.Inparticular,the,companyrec...
(Date:11/24/2009)...e/--BlueMarbleEnergyCorp.announcedtodaythatthecomp...erecentlyawarded$2millionbyWashingtonState,sCommun...licpartnershiptoconstructthestate,sfirstspecialtyb...isinvestmentwillsignificantlyspeedthedevelopmentof...ty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wearegrat...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...for Animals to be Produced in Changzhou Hi-Tech ...OU, China, April 25 /Xinhua-PRNewswire/ -- A proje...s was recently launched in,Changzhou National High...s,is a new product developed by a team of leading ... first time for China will produce this kind of,hi...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) today repo... March 31, 2008., For the quarter ended March 31,...llion, or $0.53 per share. This compares to a net ... prior quarter ended December 31, 2007,and $55.1 m...n 2007., For the quarter ended March 31, 2008, th...
...ts and Collaborators Publish Study in Science, DR...the,leading developer of RAFT intervention therape...in Science demonstrating a potential novel strateg...other diseases by targeting,discrete sub-compartme...ted,by JADO scientists together with several acade...
Other Biology Technology:Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 2Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 3CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildli...port revealing that the last remaining population ...ly due to the rising tide of poaching and habitat ...p inform Russian officials of what needs to be don...biggest cat. , The report was relea...
(Date:11/23/2009)...TINew research presents strong evidence that the "... outdoor traffic-related pollution and indoor endo...e or the other exposure alone. , Environmental... (UC) College of Medicine have shown that children...rticles and indoor endotoxin during early life are...
(Date:11/23/2009)...Calif. -- More than 160 participants gathered this...ck FUTURES INITIATIVE conference. This year,s topi...s, engineers, and medical researchers to explore t...ounding the emerging field of synthetic biology. ,...gy at Princeton University and this year,s confere...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Derma Sciences Files S 1 Registration Statement 6296 1Derma Sciences Files S 1 Registration Statement 6296 2Derma Sciences Files S 1 Registration Statement 6296 3Pharmacists Work with Congress to Address PBM Abuses 6292 1Pharmacists Work with Congress to Address PBM Abuses 6292 2Migraine Increases Likelihood of Stroke 61426 1Migraine Increases Likelihood of Stroke 61426 2
...ction of a protein called vasostatin may prove a p...ggests research published ahead of print in Gut. ,...ancer deaths in the developed world, and is extrem...ts are still alive five years after diagnosis, a s... three decades. , Currently, the only viable trea...
...nts, tiny metal scaffolds inserted into blood vess...s with heart disease, by reducing the risk of infl...new technique, using a compound that binds in an e...ve potential uses in other areas of medicine that ...quently treat heart disease patients now by using ...
... Genome-Wide RNAi Global Initiative, an alliance o...rmed to speed scientific and medical discoveries t...nitiative is sponsored by Dharmacon, Inc. , manuf...ibrary, or compilation of short, interfering ribon...determine when individual genes are functioning. I...
Other Biology News:Jefferson researchers find nanoparticle shows promise in reducing radiation side effects 2Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies 2Yale participates in global human genome initiative 2
Rattler Plating Beads from Zymo Research
di-3-ANEPPDHQ from Molecular Probes (Invitrogen)
TEMPLIPHI HT SEQ AMPL KIT from GE Healthcare, formerly Amersham Biosciences
RayBio Human Inflammation Antibody Array III & 3.1 Service from Raybiotech, Inc.
Biology Products: